Biomimetic Nanoplatform Loading Type I Aggregation-Induced Emission Photosensitizer and Glutamine Blockade to Regulate Nutrient Partitioning for Enhancing Antitumor Immunotherapy
Citations Over TimeTop 10% of 2022 papers
Abstract
The intense metabolism of cancer cells leads to hypoxia and lack of crucial nutrients in the tumor microenvironment, which hinders the function of immune cells. We designed a biomimetic immune metabolic nanoplatform, in which a type I aggregation-induced emission photosensitizer and a glutamine antagonist are encapsulated into a cancer cell membrane for achieving specific delivery in vivo. This approach greatly satisfies the glucose and glutamine required by T cells, significantly improves the tumor hypoxic environment, enables the reprogramming of tumor and immune cell metabolism, induces immunogenic cell death, promotes dendritic cell maturation, and effectively inhibits tumor proliferation. Strong tumor-specific immune responses are further triggered, and the tumor immune-suppressing microenvironment is modulated, by decreasing the number of immunosuppressive cells. Moreover, subsequent combination with anti-PD-1 is able to generate strong abscopal effects to prevent tumor distant metastasis and provide long-term immune memory against tumor recurrence.
Related Papers
- → Direct reprogramming 101(2010)20 cited
- → Spectrophotometrical purity and stability testing of a photosensitizer based on an indotricarbocyanine dye(2020)2 cited
- → Chapter 4 Correlation of intracellular and intratumoral photosensitizer distribution with photodynamic effect(2001)5 cited
- Numerical simulation of singlet oxygen generation by a porphyrin-based photosensitizer(2008)
- → Application of photosensitizer drug delivery system in photodynamic therapy of tumors(2013)